These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 16239760

  • 1. Drug-induced psychosis in Parkinson disease: phenomenology and correlations among psychosis rating instruments.
    Chou KL, Messing S, Oakes D, Feldman PD, Breier A, Friedman JH.
    Clin Neuropharmacol; 2005; 28(5):215-9. PubMed ID: 16239760
    [Abstract] [Full Text] [Related]

  • 2. Comprehensive identification of delusions and olfactory, tactile, gustatory, and minor hallucinations in Parkinson's disease psychosis.
    Kulick CV, Montgomery KM, Nirenberg MJ.
    Parkinsonism Relat Disord; 2018 Sep; 54():40-45. PubMed ID: 29653909
    [Abstract] [Full Text] [Related]

  • 3. Differences in the symptom profile of methamphetamine-related psychosis and primary psychotic disorders.
    McKetin R, Baker AL, Dawe S, Voce A, Lubman DI.
    Psychiatry Res; 2017 May; 251():349-354. PubMed ID: 28282630
    [Abstract] [Full Text] [Related]

  • 4. Scales to assess psychosis in Parkinson's disease: Critique and recommendations.
    Fernandez HH, Aarsland D, Fénelon G, Friedman JH, Marsh L, Tröster AI, Poewe W, Rascol O, Sampaio C, Stebbins GT, Goetz CG.
    Mov Disord; 2008 Mar 15; 23(4):484-500. PubMed ID: 18175343
    [Abstract] [Full Text] [Related]

  • 5. Threatening auditory hallucinations and Cotard syndrome in Parkinson disease.
    Factor SA, Molho ES.
    Clin Neuropharmacol; 2004 Mar 15; 27(5):205-7. PubMed ID: 15602098
    [Abstract] [Full Text] [Related]

  • 6. Characteristics, correlates, and assessment of psychosis in Parkinson disease without dementia.
    Barrett MJ, Smolkin ME, Flanigan JL, Shah BB, Harrison MB, Sperling SA.
    Parkinsonism Relat Disord; 2017 Oct 15; 43():56-60. PubMed ID: 28735797
    [Abstract] [Full Text] [Related]

  • 7. Cocaine-induced psychosis.
    Brady KT, Lydiard RB, Malcolm R, Ballenger JC.
    J Clin Psychiatry; 1991 Dec 15; 52(12):509-12. PubMed ID: 1752853
    [Abstract] [Full Text] [Related]

  • 8. Quetiapine improves visual hallucinations in Parkinson disease but not through normalization of sleep architecture: results from a double-blind clinical-polysomnography study.
    Fernandez HH, Okun MS, Rodriguez RL, Malaty IA, Romrell J, Sun A, Wu SS, Pillarisetty S, Nyathappa A, Eisenschenk S.
    Int J Neurosci; 2009 Dec 15; 119(12):2196-205. PubMed ID: 19916848
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of olanzapine in the treatment of psychosis in dementia with lewy bodies.
    Cummings JL, Street J, Masterman D, Clark WS.
    Dement Geriatr Cogn Disord; 2002 Dec 15; 13(2):67-73. PubMed ID: 11844887
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Clinical features, course and treatment of methamphetamine-induced psychosis in psychiatric inpatients.
    Zarrabi H, Khalkhali M, Hamidi A, Ahmadi R, Zavarmousavi M.
    BMC Psychiatry; 2016 Feb 25; 16():44. PubMed ID: 26911516
    [Abstract] [Full Text] [Related]

  • 14. Management of hallucinations and psychosis in Parkinson's disease.
    Eng ML, Welty TE.
    Am J Geriatr Pharmacother; 2010 Aug 25; 8(4):316-30. PubMed ID: 20869621
    [Abstract] [Full Text] [Related]

  • 15. Olanzapine versus placebo in the treatment of psychosis with or without associated behavioral disturbances in patients with Alzheimer's disease.
    De Deyn PP, Carrasco MM, Deberdt W, Jeandel C, Hay DP, Feldman PD, Young CA, Lehman DL, Breier A.
    Int J Geriatr Psychiatry; 2004 Feb 25; 19(2):115-26. PubMed ID: 14758577
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: a community-based study.
    Aarsland D, Larsen JP, Cummins JL, Laake K.
    Arch Neurol; 1999 May 25; 56(5):595-601. PubMed ID: 10328255
    [Abstract] [Full Text] [Related]

  • 18. Delusions and hallucinations of cocaine abusers and paranoid schizophrenics: a comparative study.
    Mitchell J, Vierkant AD.
    J Psychol; 1991 May 25; 125(3):301-10. PubMed ID: 1880755
    [Abstract] [Full Text] [Related]

  • 19. Exacerbation of psychosis triggered by a synthetic cannabinoid in a 70-year-old woman with Parkinson disease.
    Udow SJ, Freitas ME, Fox SH, Lang AE.
    CMAJ; 2018 Jan 15; 190(2):E50-E52. PubMed ID: 29335263
    [No Abstract] [Full Text] [Related]

  • 20. Minor hallucinations occur in drug-naive Parkinson's disease patients, even from the premotor phase.
    Pagonabarraga J, Martinez-Horta S, Fernández de Bobadilla R, Pérez J, Ribosa-Nogué R, Marín J, Pascual-Sedano B, García C, Gironell A, Kulisevsky J.
    Mov Disord; 2016 Jan 15; 31(1):45-52. PubMed ID: 26408291
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.